Ayerst, McKenna & Harrison, Inc.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Ayerst, McKenna & Harrison, Inc..The latest application filed is for "use of rapamycin in treatment of tumors".

Company Profile

0.20.0

Ayerst, McKenna & Harrison, Inc. - St. Laurent CA
Ayerst, McKenna & Harrison, Inc. - Montreal CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Use of rapamycin in treatment of tumors Grant 5,206,018 - Sehgal , et al. April 27, 1	1993-04-27
2-(4-Hydroxyalkyl-1-piperazinyl)-2,4,6-cycloheptatrien-1-one derivatives Grant 4,469,695 - Bagli , et al. September 4, 1	1984-09-04
2-(1-Piperazinyl)-2,4,6-cycloheptatrien-1-one derivatives Grant 4,469,694 - Bagli , et al. September 4, 1	1984-09-04
2-(4-Substituted alkyl-1-piperazinyl)-2,4,6-cycloheptatrien-1-one derivatives Grant 4,469,693 - Bagli , et al. September 4, 1	1984-09-04
Combination of .beta.-adrenoceptor antagonists and anxiolytic agents Grant 4,468,391 - Voith August 28, 1	1984-08-28
N-Naphthoylglycine derivatives Grant 4,439,617 - Sestanj , et al. March 27, 1	1984-03-27
Aldose reductase inhibition by 5-fluoro-2-methyl-1-[[4-(methylsulfonyl)phenyl]methylene]-1H-indene-3-ac etic acid Grant 4,423,075 - Dvornik , et al. * December 27, 1	1983-12-27
Aldose reductase inhibition by 5-fluoro-2-methyl-1-[[4-(methylthio)phenyl]me]-1H-indene-3-acetic acid Grant 4,423,074 - Dvornik , et al. * December 27, 1	1983-12-27
Combination of rapamycin and picibanil for the treatment of tumors Grant 4,401,653 - Eng August 30, 1	1983-08-30
N-(Naphthalenylthioxomethyl)aminoacid derivatives Grant 4,391,816 - Sestanj , et al. July 5, 1	1983-07-05
Antibiotic AY24,668 and process of preparation Grant 4,375,464 - Sehgal , et al. March 1, 1	1983-03-01
2-Thioxobenz[cd]indole-1(2H)-acetic acid derivatives Grant 4,369,188 - Sestanj January 18, 1	1983-01-18
Method of using gonadorelin for the treatment of benign prostatic hyperplasia Grant 4,321,260 - Auclair March 23, 1	1982-03-23
1-Oxo-5H-pyrimido[2,1-C]benzoxazine-2-carboxylic acid esters Grant 4,307,092 - Gauthier , et al. December 22, 1	1981-12-22
Aldose reductase inhibition by (Z)-5-fluoro-2-methyl-1-[[4-(methylsulfinyl)phenyl]methylene]-1H-indene- 3-acetic acid Grant 4,307,114 - Dvornik , et al. December 22, 1	1981-12-22
Thioxo-1H-benz[de]isoquinoline-2(3H)-acetic acid derivatives and antidiabetic use thereof Grant 4,254,108 - Sestanj March 3, 1	1981-03-03
3-Oxo-5H-pyrimido[2,1-c][1,4 ]benzoxazines Grant 4,254,121 - Gauthier , et al. March 3, 1	1981-03-03
1H-Benz[de]isoquinoline-2(3H)-acetic acid derivatives Grant 4,254,109 - Sestanj March 3, 1	1981-03-03
1-Oxo-5H-pyrimido[2,1-c][1,4]benzthiazine-2-carboxylic acid esters Grant 4,254,118 - Gauthier , et al. March 3, 1	1981-03-03
1,2,3,4-Tetrahydropyrrolo(1,2-A)pyrazines Grant 4,188,389 - Jirkovsky February 12, 1	1980-02-12

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.